17:59 IST
BSE
Earnings Call
Accretion Nutraveda Investor Presentation: Key Takeaways
H1 FY27 (Apr–Sep 2026): revenue ₹29.44 Cr (+109.35% YoY), EBITDA ₹6.26 Cr (21.27% margin), PAT ₹4.73 Cr (16.06% margin). Focus on capacity expansion and product diversification.